Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In 1980, the term non-alcoholic fatty liver disease (NAFLD) was introduced to describe the occurrence of fatty liver disease without the presence of other chronic liver diseases or alcohol consumption exceeding 140 grams per week for women and 210 grams per week for men. Recently, due to the frequent association of NAFLD with dysmetabolic comorbidities, it has been renamed to metabolic dysfunction-associated fatty liver disease (MAFLD) (23).
Non-Alcoholic Fatty Liver Disease (NAFLD) includes two pathologically distinct conditions: non-alcoholic fatty liver (NAFL) and [non-alcoholic steatohepatitis (NASH](brain://GiE_VzTZS0mh7…